TB-500 Complete Guide

TB-500 sits beside BPC-157 as the other half of the most popular research peptide pair in Canada. Both compounds were originally studied for their effect on tissue healing, but TB-500 works through a different mechanism and reaches injuries BPC-157 alone has a harder time touching. This guide covers what TB-500 actually is, what the research shows, how Canadian researchers approach reconstitution and dosing, and what to look for when sourcing it domestically.

What TB-500 Actually Is

TB-500 is a synthetic peptide fragment of Thymosin Beta-4, a naturally occurring 43 amino acid protein found in nearly every cell in the human body. The synthetic version replicates the active region of the parent protein. It is shorter, easier to manufacture and more bioavailable when injected.

The parent protein is upregulated at sites of tissue damage as part of the body’s normal repair response. The TB-500 fragment delivers a concentrated dose of that healing signal regardless of where the injury sits.

Mechanism of Action

TB-500 works through several pathways that distinguish it from BPC-157:

• Actin binding. TB-500 binds G-actin, the building block of the cellular cytoskeleton. This allows cells to migrate toward sites of injury more efficiently.
• Angiogenesis. Stimulates new blood vessel formation, which feeds repair tissue with oxygen and nutrients.
• Anti-inflammatory signaling. Down-regulates inflammatory cytokines at the injury site without suppressing the broader immune response.
• Systemic distribution. Unlike BPC-157, which acts most strongly locally, TB-500 travels through the bloodstream and reaches deep tissue, joints and connective structures that injection-site peptides cannot easily access.

That last point is why researchers pair TB-500 with BPC-157. BPC-157 hits the local site hard; TB-500 covers everything else.

Research Highlights

• Soft tissue and tendon repair. Animal studies have shown faster recovery from tendon and ligament injuries compared to controls.
• Muscle injury recovery. Significant reductions in healing time observed in rat models of skeletal muscle damage.
• Cardiac tissue. Pre-clinical research has investigated TB-500 as a candidate for myocardial repair after cardiac events.
• Wound healing. Topical and systemic Thymosin Beta-4 trials in humans have demonstrated accelerated wound closure rates.
• Hair growth. Several studies have noted hair follicle stem cell activation as a downstream effect of TB-500 administration.

Note that all human-applicable data referenced above relates to the parent protein Thymosin Beta-4 and pre-clinical TB-500 research. TB-500 itself remains a research compound in Canada and is not approved for human use.

Standard Research Protocols

Reconstitution

TB-500 ships as a lyophilized white powder. Standard reconstitution uses bacteriostatic water:

• 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL. A 0.2 mL draw = 0.5 mg.
• 5 mg vial + 5 mL bacteriostatic water = 1 mg/mL. A 0.5 mL draw = 0.5 mg. Easier math, fuller syringe.
• 2 mg vial + 2 mL bacteriostatic water = 1 mg/mL. Simplest for small protocols.

For a deeper walkthrough see our peptide reconstitution guide. The math, the technique and the storage rules are identical between TB-500 and most other peptides.

Storage and Stability

• Lyophilized (unmixed): Refrigerator. Stable for 24+ months. Freezer storage extends shelf life further.
• Reconstituted: Refrigerator. Stable 30 days when mixed with bacteriostatic water, 7 to 10 days with sterile water.
• Light exposure: Keep wrapped or in original carton. UV degrades peptide chains.
• Avoid repeated temperature cycling. Pull, draw, return to fridge. Do not let the vial sit warm between doses.

Why Pair TB-500 With BPC-157

The two compounds cover complementary territory. BPC-157 acts heavily at the injection site and through the gut, with strong local healing and gastric protection. TB-500 travels systemically, hits deep tissue and supports cell migration to wherever the body is repairing. Researchers running both together typically report results that neither alone produces inside the same window.

For the BPC-157 mechanism and dose detail, see our BPC-157 complete guide.

What Canadian Buyers Should Know

TB-500 is sold as a research compound in Canada. It is not approved for human use, not regulated by Health Canada for therapeutic claims, and any purchase must be for research purposes. That said, the Canadian peptide market has matured significantly since 2023 and domestic sourcing now reliably outperforms international shipping. Key things to verify before any order:

• Domestic supplier. Avoids customs seizure and weeks of transit instability for a temperature-sensitive compound.
• Third-party purity testing. COA available on request, ideally on the product page.
• Mass spectrometry confirmation. Confirms the molecular weight matches TB-500. Cuts the risk of mislabeled product.
• Cold-pack shipping. Lyophilized TB-500 is stable at room temperature for short periods but quality vendors still ship cold.
• Clear labelling. Vial should show compound, mass, batch number, expiry.

For the broader buyer-side checklist, see our research peptides for sale in Canada guide and peptides in Canada legality and sourcing overview.

Common Research Notes

1. TB-500 takes longer to show effects than BPC-157. Most logs report meaningful results from week 3 onward.
2. Injection site does not matter much. Systemic distribution means a single subcutaneous site (abdomen, thigh) works equally well.
3. Loading phase first, then maintenance. Skipping the loading phase delays the response.
4. Cycle, do not run continuously. Most protocols run 4 to 6 weeks then pause. Sustained year-round use has limited research backing.
5. Track bloodwork if running long-term. Baseline panel before, repeat panel after every cycle.

Quick Recap

1. TB-500 is a synthetic fragment of Thymosin Beta-4, focused on systemic tissue repair.
2. Mechanism centres on actin binding, angiogenesis and cell migration.
3. Loading 4 to 10 mg per week for 4 to 6 weeks, then maintenance.
4. Pairs naturally with BPC-157 for full local plus systemic coverage.
5. Reconstitute with bacteriostatic water, store cold and dark, use within 30 days mixed.
6. Buy domestic, third-party tested, cold-shipped, properly labelled.

TB-500 is the systemic counterpart to BPC-157 and the second half of the most replicated healing protocol in Canadian peptide research. Source it carefully, run it on protocol, and pair it with the right local-acting peptide for the goal.